8-KOther Events

WELLTOWER INC. 8-K Report, Corporate Update (Mar 7, 2013)

Filed March 7, 2013For Securities:WELL

Summary

This 8-K filing from Health Care REIT, Inc. (now Welltower Inc.) on March 7, 2013, primarily discloses the establishment of a Rule 10b5-1 trading plan by its Chairman, CEO, and President, George L. Chapman. This plan allows for the sale of a specified number of company shares and the exercise and sale of options within a defined timeframe, from March 8, 2013, to August 30, 2013. The purpose of these plans is to provide an affirmative defense against insider trading allegations by ensuring transactions are pre-arranged when the executive is not in possession of material non-public information. For investors, this filing indicates proactive compliance with insider trading regulations by a key executive. While the plan outlines the *intent* to sell shares and exercise options, actual transactions will be reported separately on Form 4 filings. The total number of shares intended for sale is significant, but the plan's structure is designed to meet regulatory requirements and maintain transparency in executive stock transactions.

Key Highlights

  • 1Health Care REIT, Inc. (now Welltower Inc.) filed an 8-K on March 7, 2013.
  • 2The filing reports the adoption of a Rule 10b5-1 trading plan by CEO George L. Chapman.
  • 3The plan allows Mr. Chapman to sell up to 35,952 shares of common stock.
  • 4The plan also permits the exercise and sale of up to 48,052 shares underlying stock options.
  • 5A portion of the options (1,959 shares) are designated to be exercised and held.
  • 6The trading window for this plan is from March 8, 2013, to August 30, 2013.
  • 7The Rule 10b5-1 plan is a compliance mechanism to avoid insider trading concerns.

Frequently Asked Questions

The primary purpose of this 8-K filing is to inform the public that George L. Chapman, the Chairman, CEO, and President of Health Care REIT, Inc. (now Welltower Inc.), has entered into a pre-arranged trading plan under SEC Rule 10b5-1.

The plan allows Mr. Chapman to sell up to 35,952 shares of the company's common stock and to exercise and sell up to 48,052 shares acquired through stock options. He will also exercise and hold 1,959 shares from options. These transactions are scheduled to occur between March 8, 2013, and August 30, 2013.

Rule 10b5-1 plans are important because they provide an affirmative defense against accusations of insider trading. They allow executives to sell company stock at predetermined times and prices, ensuring these transactions are not based on material non-public information that may become known to the executive later.

The plan outlines the maximum number of shares and options that *may* be sold. Actual sales depend on market conditions and Mr. Chapman's discretion within the plan's parameters. Details of any actual sales will be reported by Mr. Chapman on Form 4 filings with the SEC.